| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $1.54B | $156.94M | $40.87M | $24.41M | $0.13 | 2,387.61% | N/A | N/A | N/A | |||
| CORT | CORCEPT THERAPEUTICS INC | $7.67B | $963.65M | $110.92M | $159.33M | $1.51 | 30.02% | 22.25% | 51.00% | 10.66% | |||
| FENC | FENNEC PHARMACEUTICALS INC | $479.44M | $66.37M | $2.83M | $2.03M | $0.04 | 71.09% | 229.84% | N/A | N/A | |||
| TGTX | TG THERAPEUTICS INC | $9.48B | $897.76M | $196.32M | $106.06M | $0.78 | 68.78% | 189.62% | -74.59% | N/A | |||
| LGND | LIGAND PHARMACEUTICALS INC | $5.88B | $253.83M | $98.44M | $51.46M | $2.65 | 1.03% | 0.16% | 14.72% | -8.45% | |||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $3.46B | $508.68M | $46.79M | $29.91M | $0.22 | 60.00% | N/A | N/A | N/A | |||
| RPRX | ROYALTY PHARMA PLC | $39.40B | $2.62B | $1.04B | $671.45M | $1.53 | 11.36% | 2.74% | -13.07% | -4.64% | |||
| KRYS | KRYSTAL BIOTECH INC | $8.85B | $470.03M | $265.54M | $225.17M | $7.66 | 25.96% | N/A | 11.01% | N/A | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $7.47B | $945.96M | $152.02M | $109.57M | $1.43 | 58.19% | 116.69% | 191.84% | N/A | |||
| HALO | HALOZYME THERAPEUTICS INC | $10.94B | $1.80B | $805.64M | $485.42M | $4.24 | 45.03% | 31.24% | -13.29% | 7.82% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15.45B | $4.72B | $1.15B | $205.95M | $3.64 | 13.48% | 10.51% | N/A | N/A | |||
| ADMA | ADMA BIOLOGICS INC | $3.02B | $519.15M | $252.60M | $182.41M | $0.79 | 6.26% | 49.93% | -10.23% | N/A | |||
| VCEL | VERICEL CORP | $2.95B | $324.17M | $53.93M | $33.31M | $0.66 | 25.30% | 16.08% | 153.85% | 131.16% | |||
| TECH | BIO-TECHNE CORP | $11.41B | $1.23B | $333.76M | $171.97M | $1.10 | 0.94% | 4.52% | 120.00% | -0.71% | 2026-11-18 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $559.34M | $147.76M | $96.13M | $78.02M | $1.27 | 75.10% | 39.04% | 164.58% | N/A | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $135.44B | $12.95B | $5.04B | $3.98B | $15.67 | 10.48% | 12.68% | 9.50% | 13.23% | |||
| INCY | INCYTE CORP | $24.27B | $6.01B | $896.98M | $403.41M | $2.09 | 24.88% | 15.59% | -65.40% | -2.97% | |||
| EXEL | EXELIXIS INC | $16.71B | $2.50B | $1.12B | $885.14M | $3.45 | 9.12% | 14.77% | 40.24% | 45.45% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.94B | $989.36M | $271.21M | $178.60M | $3.09 | 19.79% | 29.61% | -4.33% | 10.45% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $99.08B | $16.90B | $6.25B | $4.82B | $47.01 | 18.59% | 4.52% | 8.19% | -6.64% | |||
| UTHR | UNITED THERAPEUTICS CORP | $24.88B | $3.19B | $1.62B | $1.23B | $28.57 | 1.89% | 14.00% | 0.32% | 22.59% | |||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $205.29M | $0.00 | $1.26M | -$877.00k | $0.59 | N/A | -100.00% | N/A | N/A | |||
| VCYT | VERACYTE INC | $1.96B | $581.78M | $142.59M | $126.85M | $1.59 | 17.50% | 25.52% | 307.69% | N/A |